...
首页> 外文期刊>Journal of clinical gastroenterology >Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.
【24h】

Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.

机译:先进的同步腺瘤但不是简单的腺瘤预测切除结肠直肠癌患者的再叉瘤的未来发展。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Patients with resected colorectal cancer remain at a high risk for developing metachronous neoplasia in the remnant colorectum. The aim of this study was to identify baseline clinical and colonoscopic features predictive of metachronous neoplasia after curative resection of colorectal cancer. METHODS: The baseline clinical and colonoscopic data and follow-up details of 503 patients who had colonoscopic surveillance after curative colorectal resection between January 2000 and October 2005 in a single tertiary institution were analyzed. Univariate and multivariate analyses were done to identify risk factors for metachronous adenoma. RESULTS: Metachronous adenomas were diagnosed in 176 patients (35.0%) and advanced adenomas in 39 (7.8%) during the follow-up period (35.7+/-20.9 mo). Among the clinical and colonoscopic factors at baseline, advanced age (> or = 60 y) (odds ratio (OR)=3.64; 95% confidence intervals (CI), 1.55-8.52), the presence of advanced synchronous adenoma (OR=4.38; 95% CI, 1.77-10.85), and longer total follow-up period (OR=1.03; 95% CI, 1.01-1.04) were independently correlated with developing advanced metachronous adenoma. Patients who had synchronous tubular adenoma without advanced features at baseline were not found to have an increased risk for future development of advanced metachronous adenoma compared with those in the synchronous adenoma-free group (OR=1.75; 95% CI, 0.69-4.43, P=0.650). CONCLUSIONS: Our data showed that patients with advanced synchronous adenoma at baseline were identified to have an increased risk of advanced metachronous neoplasia during a longer follow-up period but those with tubular adenoma without advanced features at baseline were not.
机译:背景:切除结肠直肠癌的患者仍处于在残留结肠肠中开发同学瘤周期的高风险。本研究的目的是鉴定基线临床和结肠镜的特征在结肠直肠癌治疗切除后再丧失的瘤形成预测性。方法:分析了2000年1月至2005年1月在2005年1月至2005年10月在单一三级机构的治疗结肠直肠切除后进行了503名患者的基线临床和结肠镜诊断和后续细节。进行单变量和多变量分析以确定同赤鳞腺瘤的危险因素。结果:在后续期间(7.8%)(35.7 +/- 20.9 Mo),在176名患者(35.0%)和晚期腺瘤(35.7 +/- 20.9 mo)中被诊断为176名患者(35.0%)和晚期腺瘤。在基线的临床和结肠镜检查中,晚期(>或= 60 y)(差距(或)= 3.64; 95%置信区间(CI),1.55-8.52),存在先进的同步腺瘤(或= 4.38 ; 95%CI,1.77-10.85),较长的总随访时间(或= 1.03; 95%CI,1.01-1.04)与开发先进的相位腺瘤不同相关。没有在基线上没有先进特征的同步管状腺瘤的患者没有增加未来的再叉续腺瘤的未来发展风险,而无同步腺瘤的组(或= 1.75; 95%CI,0.69-4.43,P = 0.650)。结论:我们的数据显示,在基线上进行高级同步腺瘤的患者在较长的随访期间,在较长的随访期间具有增加的高级同胞瘤形成的风险,但没有在基线下没有先进特征的管状腺瘤的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号